Specialty Area
Spotlight
Topics
Institute for Value-Based Medicine
About AJMC
Podcasts
CE
Subscribe
- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Katy Beckermann, MD
Katy Beckermann, MD, PhD, is an assistant professor of medicine at Vanderbilt University Medical Center, and medical director of genitourinary clinical research at Tennessee Oncology.
Articles
PROs Similar With Tivozanib Monotherapy vs Combination in RCC
February 17th 2025Patient-reported outcomes (PROs) were similar among those treated with tivozanib monotherapy and those given combination tivozanib and nivolumab in for renal cell carcinoma (RCC) in the TiNivo-2 study, according to a poster presented at the American Society of Clinical Oncology Genitourinary Cancers Symposium by Katy Beckermann, MD, PhD.
